A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...

Living with PH, it's easy to focus on what we can't do instead of what we can. Columnist Colleen Steele's advice? Don't limit ...

The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...

Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...

Chronic pain can be particularly difficult to manage during the holidays, says columnist Jen Cueva, who shares how PH disrupted her plans.

People with pulmonary arterial hypertension (PAH) and their physicians hardly ever agree on the severity of symptoms, a study in the U.S., Europe and Japan reveals. Symptom discordance was more likely ...